S-BIOTEK ApS: Financial statements 2023
CVR: 29420297
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
S-BIOTEK ApS (CVR 29420297) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -3,750 and a net result of DKK -3,750 compared with DKK 395,829 the year before. Equity in the 2023 report amounted to DKK -8,750.
- Gross Profit
- DKK -3,750
- Profit/Loss
- DKK -3,750
- Equity
- DKK -8,750
- Total Assets
- DKK 0
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -4 t. | -4 t. | -9 t. | 0 |
| 2022 | - | -6 t. | 396 t. | -5 t. | 0 |
| 2021 | - | -6 t. | -25 t. | -424 t. | - |
| 2020 | - | -6 t. | -22 t. | -399 t. | - |
| 2019 | - | -6 t. | -21 t. | -377 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout S-BIOTEK ApS
S-BIOTEK ApS was a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2006. The company has been dissolved on 11 January 2024. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DS 50 ApS. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK -3,750 and a net result of DKK -3,750 compared with DKK 395,829 the year before. Equity in the 2023 report amounted to DKK -8,750.